United States · Growth startup
6 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$434Mraised across 6 rounds since 2004, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $300M sold, first sale Nov 2010
Reported by reatapharma.comSEC filing: $17M sold, first sale Sept 2009
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Feb 2010
No investor was named in the report.
From a historical funding recordSEC filing: $17M sold, first sale Sept 2009
Startech Early VenturesFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Startech Early VenturesCardinal Investment Co.Ojai GoliadUniversity of TexasMissing a round, or an investor who was in one? Tell us.
Reata Pharmaceuticals's investors include Novo Holdings A/S, CPMG, Startech Early Ventures, Cardinal Investment Co. and Ojai Goliad, and 1 more on record.
Reata Pharmaceuticals has raised $434M across 6 rounds since 2004.
Reata Pharmaceuticals's most recent round was a Growth of $300M in Jul 2011.
Its most recent round, $300M in Jul 2011, is also its largest on record.
Reata Pharmaceuticals's first round on record, in Nov 2004, was backed by Startech Early Ventures, Cardinal Investment Co. and Ojai Goliad and 1 others.
Reata Pharmaceuticals's latest named round is a Growth, in Jul 2011.
Reata Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·